25 results
Acute Coronary Syndrome NICE Guidelines 2021 - BMJ

#Acute #Coronary #Syndrome #ACS #cardiology #diagnosis #management #NICE #Guideline
Acute Coronary Syndrome ... NICE Guidelines ... Acute #Coronary #Syndrome ... #ACS #cardiology ... #2021 #BMJ #ACS
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... 2013 ACCF/AHA Guideline ... American College of Cardiology ... #ACCAHA2017 #cardiology ... #treatment #algorithm
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Recommendations for the Treatment ... - Invasive syndromes ... or colonizing syndromes ... Aspergillosis #Treatment ... #pharmacology #
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
Antiphospholipid Syndrome ... to be present Treatment ... (EULAR Guidelines ... Antiphospholipid #Syndrome ... anticoagulation #guidelines
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... long-acting β2-agonist; ICS ... GOLD2017 #LAMA #LABA #ICS ... #Guidelines
Migraine - Preventative Treatments

 • Anticonvulsants: *Topiramate, *Sodium valproate, Gabapentin, Pregabalin
 • Antidepressants: Amitriptyline, Venlafaxine, Duloxetine,
- Preventative Treatments ... Beta-blockers, ACE ... #Preventative #Treatment ... prophylaxis #prevention #pharmacology ... #neurology
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... functional ID) Guidelines ... : • ACC/AHA 2017 ... management #algorithm #cardiology ... #treatment #guidelines
Pharmacological Treatment of Hepatorenal Syndrome (HRS)

Midodrine - Alpha agonist incr blood pressure incr renal perfusion pressure
Pharmacological Treatment ... of Hepatorenal Syndrome ... #HepatoRenal #Syndrome ... #Pharmacology # ... Medications #Treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... low, adding an ICS ... #Indications #Pharmacology
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... /AHA guidelines. ... HeartFailure #HFrEF #Pharmacology ... #Management #Treatment ... #StageC #Cardiology